Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD) has exercised its option to exclusively license Assembly Biosciences, Inc.’s (NASDAQ:ASMB) herpes simplex virus (HSV) helicase-primase ...
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its ...
An investigation into what appeared at first glance to be a “standard” Python-based infostealer campaign took an interesting turn when it was discovered to culminate in the deployment of a ...
Mikeie Reiland is a staff writer for Education at Forbes Advisor. Before coming to Forbes Advisor, he wrote magazine journalism for publications like the Oxford American, Bitter Southerner, and Gravy.
Investors in Genpact Ltd (Symbol: G) saw new options begin trading today, for the January 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the ...
The Python Software Foundation team has invalidated all PyPI tokens stolen in the GhostAction supply chain attack in early September, confirming that the threat actors didn't abuse them to publish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback